← Eichor
Study identifier: NCT07484464 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of the Otago Exercise Program on Balance, Endurance, and Motor Coordination in Children With Down Syndrome

Condition: Down Syndrome  ·  Sponsor: Riphah International University

PhaseNA
Planned participants30
Who can joinAll sexes, 8 Years to 14 Years
Healthy volunteersNo

About this study

The study will use a quasi-experimental design conducted over ten months in pediatric physiotherapy departments of tertiary care hospitals and special education schools. It will include 30 children aged 6-14 years with mild to moderate intellectual disability, selected after eligibility screening and guardian consent. Outcomes will be assessed using BOT-2, Berg Balance Scale, MMSE-C, and Six-Minute Walk Test to measure motor skills, balance, cognition, and endurance. Ethical approval will be obtained from the Research Ethical Committee of Riphah International University, Lahore, and data will be analyzed using SPSS version 26.0.

This description comes directly from the study's public registry record.

Talk to the study team

IMRAN AMJAD, PhD  ·  9233224390125  ·  imran.amjad@riphah.edu.pk

MUHAMMAD ASIF JAVED, MS-PT  ·  923224209422  ·  a.javed@riphah.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Gulab DeviLahore, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07484464